Kyowa Kirin is a fast-growing global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines in four disease areas: bone and mineral; intractable hematologic; hematology oncology; and rare disease. A Japan-based company, our goal is to translate science into smiles by delivering therapies where no adequate treatments currently exist, working from drug discovery to product development and commercialization. In North America, we are headquartered in Princeton, NJ, with offices in California, North Carolina, and Mississauga, Ontario. Summary of Job: Let’s work together to make people smile in this vital role to shape the US launch of Rocatinlimab, an anti-OX40 human monoclonal antibody being investigated in partnership with Amgen for the treatment of atopic dermatitis, asthma, prurigo nodularis, and other inflammatory diseases. The Director, HCP Inflammation Marketing will lead and influence a cross-functional team to rapidly advance the pipeline of inflammation products. They are responsible for the development and implementation of product strategy and promotional plans designed to achieve US sales objectives. Internally and in collaboration with alliance partners, they will work in cross-functional matrix teams, manage external agencies and ensure the alignment of stakeholders to meet goals. This is a pivotal launch role requiring extensive collaboration in an alliance setting, effective communication and planning skills, and innovative problem-solving capabilities. It also requires broad experience in the inflammation marketing space, launch leadership experience, biologics/ specialty pharmacy operations and strong scientific acumen.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
5,001-10,000 employees